Patents Assigned to Solarvest BioEnergy Inc.
  • Patent number: 11490639
    Abstract: Dental compositions that comprise algae are disclosed. Methods of use of the dental compositions, including methods of reducing plaque on at least one tooth of an animal using the dental compositions, are also disclosed.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: November 8, 2022
    Assignee: Solarvest BioEnergy Inc.
    Inventor: Richard E. Wagner
  • Patent number: 10941408
    Abstract: This invention relates to systems, methods, and devices for inducing andlor repressing the expression of proteins. More particularly, the invention relates to systems, methods, and devices for inducing andlor repressing the expression of proteins in plastids. An exemplary embodiment involves the regulation of the expression of proteins involved in hydrogen production to stimulate the production of hydrogen gas using the methods, systems, and devices described herein.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: March 9, 2021
    Assignee: SOLARVEST BIOENERGY INC.
    Inventors: Richard E. Wagner, Raymond Surzycki, Jean-David Rochaix
  • Patent number: 9527893
    Abstract: The present disclosure provides a modified cecropin protein comprising a cecropin or a variant thereof fused to a hydrophilic tail lacking a C-terminal glycine. The present disclosure also provides pharmaceutical compositions, methods and uses of the modified cecropin protein or nucleic acid for treating or preventing endoparasites, such as Plasmodium, and bacteria.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: December 27, 2016
    Assignee: SOLARVEST BIOENERGY INC.
    Inventors: Subrata Chowdhury, Michael Thomas Horne
  • Patent number: 9228193
    Abstract: This invention relates to systems, methods, and devices for inducing and/or repressing the expression of proteins. More particularly, the invention relates to systems, methods, and devices for inducing and/or repressing the expression of proteins in plastids. An exemplary embodiment involves the regulation of the expression of proteins involved in hydrogen production to stimulate the production of hydrogen gas using the methods, systems, and devices described herein.
    Type: Grant
    Filed: August 11, 2007
    Date of Patent: January 5, 2016
    Assignee: Solarvest Bioenergy Inc.
    Inventors: Raymond Surzycki, Jean-David Rochaix, Richard E. Wagner
  • Publication number: 20140170124
    Abstract: The present disclosure provides a modified cecropin protein comprising a cecropin or a variant thereof fused to a hydrophilic tail lacking a C-terminal glycine. The present disclosure also provides pharmaceutical compositions, methods and uses of the modified cecropin protein or nucleic acid for treating or preventing endoparasites, such as Plasmodium, and bacteria.
    Type: Application
    Filed: July 13, 2012
    Publication date: June 19, 2014
    Applicant: SOLARVEST BIOENERGY INC.
    Inventors: Subrata Chowdhury, Michael Thomas Horne
  • Publication number: 20140127254
    Abstract: Delivery systems and methods are provided for delivering a biologically active protein to a host animal. The systems and methods provided include obtaining an algal cell transformed by an expression vector, the expression vector comprising a nucleotide sequence coding for the biologically active protein, operably linked to a promoter. In one illustrated embodiment, the biologically active protein is an antigenic epitope and upon administration to the animal the algal cell induces an immune response in the host animal.
    Type: Application
    Filed: May 28, 2013
    Publication date: May 8, 2014
    Applicants: The Ohio State University, Solarvest BioEnergy Inc.
    Inventors: Richard T. Sayre, Richard E. Wagner, Surasak Siripornadulsil, Carlos Farias